Pharma investor’s award against Ecuador upheld – GAR

0
19

A Merck facility in San Francisco (Credit: Shutterstock/Tada Images)

A Dutch court has upheld a US pharmaceuticals company’s €44 million investment treaty award against Ecuador, dismissing arguments that the arbitrators took on the role of a final appeal court when they held the state liable for a denial of justice.

LEAVE A REPLY

Please enter your comment!
Please enter your name here